Cargando…
AI in medicine: Where are we now and where are we going?
Advancements in AI enable personalizing healthcare, for example by investigating disease origins at the genetic or molecular level, understanding intraindividual drug effects, and fusing multi-modal personal physiological, behavioral, laboratory, and clinical data to uncover new aspects of pathophys...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798019/ https://www.ncbi.nlm.nih.gov/pubmed/36543109 http://dx.doi.org/10.1016/j.xcrm.2022.100861 |
_version_ | 1784860814714339328 |
---|---|
author | Shandhi, Md Mobashir Hasan Dunn, Jessilyn P. |
author_facet | Shandhi, Md Mobashir Hasan Dunn, Jessilyn P. |
author_sort | Shandhi, Md Mobashir Hasan |
collection | PubMed |
description | Advancements in AI enable personalizing healthcare, for example by investigating disease origins at the genetic or molecular level, understanding intraindividual drug effects, and fusing multi-modal personal physiological, behavioral, laboratory, and clinical data to uncover new aspects of pathophysiology. Future efforts should address equity, fairness, explainability, and generalizability of AI models. |
format | Online Article Text |
id | pubmed-9798019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-97980192022-12-30 AI in medicine: Where are we now and where are we going? Shandhi, Md Mobashir Hasan Dunn, Jessilyn P. Cell Rep Med Commentary Advancements in AI enable personalizing healthcare, for example by investigating disease origins at the genetic or molecular level, understanding intraindividual drug effects, and fusing multi-modal personal physiological, behavioral, laboratory, and clinical data to uncover new aspects of pathophysiology. Future efforts should address equity, fairness, explainability, and generalizability of AI models. Elsevier 2022-12-20 /pmc/articles/PMC9798019/ /pubmed/36543109 http://dx.doi.org/10.1016/j.xcrm.2022.100861 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Shandhi, Md Mobashir Hasan Dunn, Jessilyn P. AI in medicine: Where are we now and where are we going? |
title | AI in medicine: Where are we now and where are we going? |
title_full | AI in medicine: Where are we now and where are we going? |
title_fullStr | AI in medicine: Where are we now and where are we going? |
title_full_unstemmed | AI in medicine: Where are we now and where are we going? |
title_short | AI in medicine: Where are we now and where are we going? |
title_sort | ai in medicine: where are we now and where are we going? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798019/ https://www.ncbi.nlm.nih.gov/pubmed/36543109 http://dx.doi.org/10.1016/j.xcrm.2022.100861 |
work_keys_str_mv | AT shandhimdmobashirhasan aiinmedicinewherearewenowandwherearewegoing AT dunnjessilynp aiinmedicinewherearewenowandwherearewegoing |